|
 |
oral transmucosal fentanyl citrateThis page contains recent news articles, when available, and an overview of oral transmucosal fentanyl citrate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The product portfolio of the company includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, oral transmucosal fentanyl citrate ... PRMinds (press release) Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product - Oct 30, 2009 Oral Transmucosal Fentanyl Citrate, a Class II controlled substance, is an opioid analgesicindicated only for the management of breakthrough cancer pain in ... Reuters Mallinckrodt painkiller gets FDA OK - Nov 2, 2009 The Oral Transmucosal Fentanyl Citrate is an opiod analgesic designed for cancer patients to place inside the cheek for pain relief. ... St. Louis Business Journal Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced ... - Nov 5, 2009 PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. ... Reuters Cephalon, Inc. to Webcast R&D Day - Nov 4, 2009 GABITRIL® (tiagabine hydrochloride) and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. ... Reuters Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work ... - Nov 2, 2009 GABITRIL(R) (tiagabine hydrochloride), PROVIGIL(R) (modafinil) Tablets [C-IV], and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). ... Reuters Denbury Acquires Encore for $4.5 B; Ford Surges - Nov 2, 2009 ...said that its subsidiary, Mallinckrodt Inc., has received FDA approval of its Abbreviated New Drug Application for Oral Transmucosal Fentanyl Citrate. ... Ticker Magazine Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical ... - Oct 27, 2009 ...trioxide) injection, GABITRIL® (tiagabine hydrochloride), PROVIGIL® (modafinil) Tablets [C-IV], and ACTIQ® (oral transmucosal fentanyl citrate) (C-II). ... Reuters Hot Stocks to Watch (COV, PGR, RKT) by Penny Stock Money - Nov 2, 2009 ...maker said it received US Food and Drug Administration approval of an abbreviated new drug application for oral transmucosal fentanyl citrate. ... TransWorldNews (press release) Monday's biggest gaining and declining stocks - Nov 2, 2009 ...said that an abbreviated new-drug application by its Mallinckrodt subsidiary for oral transmucosal fentanyl citrate was cleared by the US Food and Drug ... Middle East North Africa Financial Network Cephalon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile ... - Nov 9, 2009 The product portfolio of the company includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, oral transmucosal fentanyl citrate ... PR-Inside.com (Pressemitteilung) Cephalon Appoints Bob Repella as Senior Vice President of US Pharmaceutical ... - Oct 27, 2009 GABITRIL(R) (tiagabine hydrochloride), PROVIGIL(R) (modafinil) Tablets [C-IV], and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). ... Trading Markets (press release) Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 ... - Oct 28, 2009 ...trioxide) injection, GABITRIL® (tiagabine hydrochloride), NUVIGIL® (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. ... PharmaLive.com (press release) Transmucosal fentanyl vs intravenous morphine in doses proportional... - May 22, 2007 On the other hand, studies of oral transmucosal fentanyl citrate (OTFC) have ... Oral transmucosal fentanyl citrate, given in doses proportional to the ... Nature.com Article: Cephalon's painkiller promotion questioned: A Conn. probe... - Nov 22, 2006 PR Newswire; June 5, 1998 ; 700+ words ... ... assessment of the efficacy and safety of Actiq (oral transmucosal fentanyl citrate ... announced the ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research Press Release: Study finds 90 Percent of Actiq 'Lollipop' Prescription... - Jan 16, 2007 PR Newswire; January 17, 2000 ; 700+ words ... ... net loss resulted primarily from new revenue from Actiq(R) (oral transmucosal fentanyl citrate) product ... Pay-Per-View - PR Newswire - HighBeam Research Competitors by Product Report - Dec 27, 2008 Barr Pharmaceuticals, Inc. (BRL) Products:. Meperidine Hydrochloride; Oral Transmucosal Fentanyl Citrate [C-II]; Pliva Tramadol Hydrochloride ... $75.00 - Revere - Alacra Store Competitors by Product Report - Dec 27, 2008 Actiq (Oral Transmucosal Fentanyl Citrate) [C-II]; Actiq Sugar-Free (Oral Transmucosal Fentanyl Citrate) [C-II]; Fentora (Fentanyl Buccal Tablet) ... $75.00 - Revere Reports - Revere FDA Approvals: Nevanac, Sugar-Free Actiq, Quinine Sulfate - Sep 15, 2005 9, the FDA approved a sugar-free formulation of oral transmucosal fentanyl citrate (Actiq, made by Cephalon, Inc.) for the management of breakthrough pain ... Medscape Cephalon Announces Positive Results for FENTORA(TM) (Fentanyl … - Oct 11, 2006 ...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, ... RedOrbit Cephalon Announces Positive Results from Two Phase 3 Clinical Trials... - Jan 8, 2007 ...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Receives Approvable Letter For FENTORA(TM) (fentanyl … - Jun 30, 2006 ...and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ(R) (oral transmucosal fentanyl citrate) [C- II]. ... Medical News Today - Medical News Today (press release) Achieva Ltd acquires a minority stake in CS Vision Co Ltd (pending) -... - Apr 17, 2007 Hydrochloride Oral Transmucosal Fentanyl Citrate [C-II] Pliva Tramadol Hydrochloride Baxter…Actiq (Oral Transmucosal Fentanyl Citrate) [C-II] Actiq ... Pay-Per-View - deals - Alacra Store Cephalon Receives Approvable Letter for FENTORA(TM) (Fentanyl … - Jun 29, 2006 ...and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ(R) (oral transmucosal fentanyl citrate) [C- II]. ... RedOrbit Cephalon Announces Positive Results from a Pivotal Study of FENTORA … - Aug 16, 2007 ...oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, do not substitute FENTORA on a mcg per mcg basis. ... Free with registration - PR Newswire - AccessMyLibrary.com Opioids for management of breakthrough pain in cancer patients.( … - Dec 1, 2006 Oral transmucosal fentanyl citrate (OTFC [Actiq]), a rapid-acting opioid, has been shown to be an effective treatment for breakthrough cancer pain. ... Free with registration - American Family Physician - AccessMyLibrary.com Cephalon; Cephalon officials report on new developments - Dec 5, 2006 ...than with Actiq (oral transmucosal fentanyl citrate) [C-II]. As such, Fentora delivers the therapeutic benefit of fentanyl at a lower dose than Actiq. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Cephalon Announces Executive Appointment. - Mar 4, 2005 GABITRIL(R) (tiagabine hydrochloride) and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and more than 20 products internationally. ... $4.95 - PR Newswire - ECNext Fentanyl citrate. - Nov 6, 2006 Barr Laboratories, Woodcliff Lake, N.J., (800) 222-0190, has introduced a generic version of Cephalon's ACTIQ (oral transmucosal fentanyl citrate) C-II. ... $9.94 - Drug Topics - Alacra Store Press Release: Cephalon Provides Update on Regulatory Status of the … - Jan 25, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Pay-Per-View - PR Newswire - HighBeam Research Fentanyl citrate.(NEW GENERICS)(Brief article) - Nov 6, 2006 Barr Laboratories, Woodcliff Lake, NJ, (800) 222-0190, has introduced a generic version of Cephalon's ACTIQ (oral transmucosal fentanyl citrate) C-II. $4.95 - Drug Topics - ECNext Bloomberg Printer-Friendly Page - Jun 3, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Bloomberg Sosei Announces Successful Completion of AD 923 Pharmacokinetic … - May 21, 2007 ...single dose, cross-over, randomised study of AD 923 versus Actiq(R) (oral transmucosal fentanyl citrate lozenge) and versus fentanyl citrate injection. ... Genetic Engineering News - Genetic Engineering News (press release) Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA … - Dec 4, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Cephalon Reinforces Important Prescribing and Dosing … - Sep 13, 2007 FENTORA is not bioequivalent to or a generic version of ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; therefore, FENTORA should not be substituted ... Pay-Per-View - PR Newswire - HighBeam Research CIMA LABS Drug Delivery Technology Used in Orapred ODT(TM) - Jun 19, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate), TRISENOX(R) (arsenic trioxide) injection, VIVITROL and numerous products internationally. ... RedOrbit Cephalon, Inc. Announces Agreement to Acquire Zeneus Holdings … - Dec 6, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... RedOrbit Cephalon and Alkermes Announce Agreement for the Commercialization … - Jun 24, 2005 GABITRIL(R) (tiagabine hydrochloride) and ACTIQ(R)(oral transmucosal fentanyl citrate) [C-II] , and more than 20 products internationally. ... RedOrbit Sosei Announces Successful Completion of AD 923 Pharmacokinetic … - May 22, 2007 ...single dose, cross-over, randomised study of AD 923 versus Actiq(R) (oral transmucosal fentanyl citrate lozenge) and versus fentanyl citrate injection. ... $4.95 - PR Newswire - ECNext Cephalon Announces FDA Advisory Committee Recommendation … - May 6, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... RedOrbit Press Release: Sosei Announces Successful Completion of AD 923 … - May 22, 2007 ...single dose, cross-over, randomised study of AD 923 versus Actiq(R) (oral transmucosal fentanyl citrate lozenge) and versus fentanyl citrate injection. ... Pay-Per-View - PR Newswire - HighBeam Research Cephalon (CEPH) Concludes All Outstanding Federal and State … - Sep 29, 2008 ...in 2004 and involved three of the company's nine proprietary products in the United States -- Actiq(R) (oral transmucosal fentanyl citrate) [C-II], ... StreetInsider.com - StreetInsider.com (subscription) Cephalon, Inc. Announces Agreement with Teva Pharmaceutical … - Dec 9, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy … - Mar 21, 2008 GABITRIL ® (tiagabine hydrochloride), NUVIGIL™ (armodafinil) Tablets [C-IV] and ACTIQ ® (oral transmucosal fentanyl citrate) [C-II]. ... Press Media Wire - Press Media Wire (Press Release) Fentora Cancer Pain Drug Linked To Deaths - Sep 14, 2007 Fentora should not be substituted for any fentanyl-containing pain medication, including Actiq (oral transmucosal fentanyl citrate). ... Medical News Today - Medical News Today (press release) Heroin, cancer drug mix kills 12: Wayne Co. warning issued. - May 20, 2006 FENTANYL (Oral transmucosal fentanyl citrate) -- A product of Cephalon Inc. (145 Brandywine Parkway, West Chester, PA 19380 | 800-896-5855) -- Sold as ... Free with registration - Detroit Free Press - AccessMyLibrary.com Cephalon, Inc. Moves Corporate Headquarters to Frazer, PA; Chester … - Mar 29, 2005 GABITRIL(R) (tiagabine hydrochloride) Tablets and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Receives Complete Response Letter Regarding Request for … - Sep 15, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Genetic Engineering News - Genetic Engineering News (press release) Cephalon Oncology Reports Clinical Response to CEP-701 Correlates … - Dec 12, 2005 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon, Inc. and ImmuPharma plc Sign a $15 Million Option … - Nov 25, 2008 GABITRIL® (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. ... Lifescience-online Cephalon receives approvable letter to market sugar-free formulation... - Mar 25, 2005 ...letter from the US Food and Drug Administration (FDA) to market a new sugar-free formulation of Actiq (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com FDA Extends PDUFA Date for VIVITREX(R) to December 30, 2005; … - Dec 30, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II) and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... businesswire.com Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal … - Sep 25, 2006 ...to fentanyl occurred earlier and was approximately 30 percent greater with FENTORA than with ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Genetic Engineering News - Genetic Engineering News (press release) Journal of Clinical Oncology Publishes Study of Cephalon Medication … - Jul 15, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... RedOrbit TREANDA Significantly Improves Clinical Outcomes in Patients with … - Dec 10, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Oncology Reports High Response Rates to Single Agent … - Dec 12, 2005 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX, and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Reports Another Strong Quarter - Oct 28, 2008 GABITRIL(R)(tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] andACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... International Business Times Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of … - Jun 18, 2007 ...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The Company also markets numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Pediatrics Publishes Pivotal Study Showing SPARLON(TM) Significantly ... - Dec 5, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Says FDA Continues To Evaluate Rash Case Of Sparlon Study; … - Dec 7, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) ... Free with registration - M2 Presswire - AccessMyLibrary.com Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients … - Nov 3, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... RedOrbit Cephalon Announces Record Sales and Earnings for 2006. - Feb 13, 2007 GABITRIL (tiagabine hydrochloride), and ACTIQ (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally. ... Free with registration - M2 Presswire - AccessMyLibrary.com Cephalon Receives Approval to Market Modafinil for Shift Work Sleep … - Aug 30, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection and more than 20 products internationally. ... RedOrbit Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan … - Nov 26, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Genetic Engineering News - Genetic Engineering News (press release) Cephalon, Inc. Announces Agreement with Mylan Pharmaceuticals Inc. … - Jan 10, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com PRESS RELEASE: Cephalon Announces Agreement to Acquire AMRIX - Aug 23, 2007 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and NUVIGIL(TM) (armodafinil) Tablets [C-IV]. ... FierceBiotech CEPHALON/ALKERMES SIGN PACT TO DEVELOP VIVITREX. - Aug 1, 2005 GABITRIL (tiagabine hydrochloride) and ACTIQ (oral transmucosal fentanyl citrate) [C-II] , and more than 20 products internationally. ... Entrepreneur Cephalon's EFFENTORA Receives Positive Opinion from European … - Jan 24, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Scientific Advances on Three Lead Cephalon Oncology Compounds to … - Dec 8, 2005 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX, and more than 20 products internationally. ... biotech-intelligence.com Event Brief of Q2 2007 Cephalon, Inc. Earnings Conference Call -... - Jul 31, 2007 As expected, ACTIQ sales have declined significantly since the launch of generic oral transmucosal fentanyl citrate (OTFC) last year. 2. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Cephalon Receives Approvable Letter for NUVIGIL(TM) (Armodafinil) - May 1, 2006 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and TRISENOX(R) (arsenic trioxide) injection. ... RedOrbit Cephalon Files Marketing Application for Approval of a Fentanyl … - Mar 26, 2007 GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Receives FDA Approval for TREANDA to Treat Patients With … - Oct 31, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... RedOrbit Cephalon Provides Update Related to NUVIGIL(TM) New Drug … - Mar 30, 2007 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Announces Positive Results from Its Pivotal Study of TREANDA... - Oct 23, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM) - Jan 25, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... biotech-intelligence.com Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL(TM). - Feb 1, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Granted Six Months of Pediatric Exclusivity for PROVIGIL(R) - Mar 28, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and TRISENOX(R) (arsenic trioxide) injection, and numerous products internationally. ... RedOrbit Cephalon Announces Executive Appointment; Jeff Myers Named Vice … - Jul 13, 2005 GABITRIL(R) (tiagabine hydrochloride) and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and more than 20 products internationally. ... RedOrbit Cephalon Announces Results from GABITRIL(R) Clinical Program in … - Jun 26, 2006 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(TM) (naltrexone for extended-release ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan … - Apr 4, 2006 GABITRIL(R) (tiagabine hydrochloride) Tablets, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and TRISENOX, and numerous products internationally ... RedOrbit FDA Grants Orphan Drug Designation to TREANDA, an Investigational … - Aug 29, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Expects Second Quarter 2006 Results to Exceed Prior … - Jul 26, 2006 ...of PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and favorable trends in gross-to-net sales discounts. ... Genetic Engineering News - Genetic Engineering News (press release) FDA Accepts TREANDA(R) New Drug Application for the Treatment of … - Feb 19, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Notified of Generic Fentanyl Buccal Tablet Filing - Apr 28, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Lifescience-online Cephalon Comments On Study Of Its Leukemia Treatment Led By … - Jan 25, 2007 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally. ... Medical News Today - Medical News Today (press release) Studies Confirm Effectiveness Of Fentanyl Lozenges For 'Breakthrough'... - Jan 26, 2006 The fentanyl lozenge, known as oral transmucosal fentanyl citrate, or OTFC, is also known by the brand name Actiq. The review comprised four randomized ... Medical News Today - Medical News Today (press release) Cephalon, Inc. - May 31, 2007 ...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The Company also markets numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com TREANDA New Drug Application for the Treatment of Chronic … - Dec 3, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare ... - Jan 7, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon General Counsel John Osborn Nominated by President Bush … - May 16, 2007 ...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The Company also markets numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Reports Record Sales and Earnings for 2006. - Feb 12, 2007 GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Announces Executive Appointments for European Operations. - Feb 14, 2005 GABITRIL(R) (tiagabine hydrochloride) and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and more than 20 products internationally. ... Free with registration - PR Newswire Europe - AccessMyLibrary.com Cephalon, Inc. Announces Agreement to Acquire Zeneus Holdings … - Jun 12, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... presseportal.de Cephalon Announces Completion of Anticipated PROVIGIL Label … - Sep 17, 2007 ...(tiagabine hydrochloride), NUVIGIL and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com FDA Approves TREANDA, a Novel Chemotherapy for Chronic … - Apr 4, 2008 GABITRIL® (tiagabine hydrochloride), NUVIGILâ„¢ (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. ... newswise.com Cephalon Presents Positive Results For FENTORA(R) In Breakthrough … - May 2, 2007 ...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, ... Medical News Today - Medical News Today (press release) Cephalon Submits New Drug Application For TREANDA For The … - Sep 22, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... Medical News Today - Medical News Today (press release) Acusphere Inc. (ACUS) Licenses Hydrophobic Drug Delivery System to … - Mar 31, 2008 GABITRIL® (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. ... Lifescience-online Cephalon post record results for 2004. - Feb 28, 2005 In 2004, sales of Provigil (modafinil) tablets increased 51% to $439.7 million; sales of Actiq (oral transmucosal fentanyl citrate) increased 45.0% to ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Frank Baldino, Jr., Chairman and Chief Executive - Jan 2, 2008 The company also markets ACTIQ® (oral transmucosal fentanyl citrate) and FENTORA® (fentanyl buccal tablet) for cancer pain, GABITRIL® (tiagabine HCl) for ... chemie.de Combining Duragesic Patches With Other Pain Medications - Jun 13, 2006 For instance, what do you think about using the Duragesic patch with oral transmucosal fentanyl citrate (OTFC [Actiq]) for breakthrough pain? ... Medscape Cephalon Reports First-Quarter Financial Results. - May 2, 2006 GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and TRISENOX(R) (arsenic trioxide) injection. ... Free with registration - PR Newswire - AccessMyLibrary.com Stocks on the Rise- PEDG, CBRX and CEPH. - May 1, 2007 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) ... Free with registration - M2 Presswire - AccessMyLibrary.com Frank Baldino, Chief Executive Officer of Cephalon, Inc., Rings the … - Nov 20, 2007 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets (C-IV) and ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II). ... NASDAQ Cephalon, Inc. to Webcast Research and Development Day. - Jun 26, 2007 ...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Added to S&P 500 Today - Nov 14, 2008 GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... International Business Times Cephalon, Inc. - Feb 7, 2007 FENTORA, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon, Inc. Completes Acquisition of Zeneus Holdings Limited. - Dec 22, 2005 ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and TRISENOX(R) (arsenic trioxide) injection, and more than 20 products internationally. ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon's 2nd-qtr 2007 sales hit $435M.(Financial report) - Aug 13, 2007 ...franchise sales reported strong turnover of $131.2 million, a decrease of 24% despite generic competition to Actiq (oral transmucosal fentanyl citrate). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Cephalon Second-Quarter Sales Increase 58 Percent. - Aug 3, 2006 ...of PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and favorable trends in gross-to-net sales discounts. ... Free with registration - PR Newswire - AccessMyLibrary.com IMPORTANT SAFETY INFORMATION FOR PATIENTS AND … - Sep 17, 2007 If you are taking ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and your doctor decides to change your medicine to FENTORA, DO NOT continue taking ... RSDSA PRESS RELEASE: Cephalon Announces Strong Third Quarter Financial … - Nov 9, 2007 ...(tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. ... FierceBiotech |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |